{"id":"atorvastatin-and-clopidogrel","safety":{"commonSideEffects":[{"rate":"3-5%","effect":"Muscle pain or myalgia"},{"rate":"1-3%","effect":"Elevated liver enzymes"},{"rate":"1-2%","effect":"Bleeding"},{"rate":"2-4%","effect":"Dyspepsia"},{"rate":"1-2%","effect":"Headache"}]},"_chembl":{"chemblId":"CHEMBL1771","moleculeType":"Small molecule","molecularWeight":"321.83"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Atorvastatin is a statin that blocks HMG-CoA reductase, reducing LDL cholesterol synthesis and lowering cardiovascular risk. Clopidogrel is a P2Y12 platelet inhibitor that prevents thrombotic events by reducing platelet aggregation. Together, they provide complementary cardioprotective effects through lipid lowering and antiplatelet mechanisms.","oneSentence":"This combination reduces cholesterol levels and prevents blood clots by inhibiting HMG-CoA reductase and platelet aggregation, respectively.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:42:45.058Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Secondary prevention of cardiovascular events in patients with acute coronary syndrome"},{"name":"Prevention of stent thrombosis following percutaneous coronary intervention"},{"name":"Reduction of cardiovascular risk in patients with established coronary artery disease"}]},"trialDetails":[{"nctId":"NCT06308952","phase":"PHASE4","title":"Atorvastatin Pretreatment in Cerebrovascular Events (APICES) After Flow Diverter Implantation","status":"RECRUITING","sponsor":"Duan Chuanzhi","startDate":"2024-07-30","conditions":"Cerebrovascular Event, Stent Stenosis, Ischemic Stroke","enrollment":354},{"nctId":"NCT07265466","phase":"PHASE1","title":"to Evaluate the Safety and the Pharmacokinetic and Pharmacodynamic Interactions Between JP-1366 and Clopidogrel, Aspirin, Atorvastatin and Apixaban","status":"RECRUITING","sponsor":"Onconic Therapeutics Inc.","startDate":"2025-11-17","conditions":"Drug Drug Interaction (DDI)","enrollment":96},{"nctId":"NCT07012629","phase":"PHASE3","title":"A EUROpean Randomized Study on Blood-thinners and Cholesterol-lowering Treatments to Prevent Future Vascular Events in People With Covert Brain Infarcts (CBI)","status":"RECRUITING","sponsor":"Aarhus University Hospital","startDate":"2025-11-26","conditions":"Covert Brain Infarction","enrollment":1652},{"nctId":"NCT06336174","phase":"","title":"Cognitive Decline and Underlying Mechanisms in Symptomatic Intracranial Artery Stenosis Patients: A Cohort Study","status":"RECRUITING","sponsor":"Anhui Medical University","startDate":"2022-11-01","conditions":"Intracranial Atherosclerosis, Cognitive Impairment, Cerebrovascular Event","enrollment":100},{"nctId":"NCT06358313","phase":"PHASE3","title":"Concomitant Use of Clopidogrel With Atorvastatin or Rosuvastatin in Patients With Moderate and Moderate-to-severe Stroke","status":"RECRUITING","sponsor":"Kafrelsheikh University","startDate":"2024-04-10","conditions":"Ischemic Stroke","enrollment":600},{"nctId":"NCT06360120","phase":"PHASE3","title":"Combining Use of Clopidogrel With Atorvastatin or Rosuvastatin in Patients With Large-vessel Ischemic Stroke","status":"RECRUITING","sponsor":"Kafrelsheikh University","startDate":"2024-04-10","conditions":"Ischemic Stroke","enrollment":600},{"nctId":"NCT07121088","phase":"PHASE4","title":"Traditional Chinese Medicine Intervention for Ischemic Cerebrovascular Disease and Diabetes Mellitus: An Efficacy Comparative Study","status":"NOT_YET_RECRUITING","sponsor":"Guangzhou University of Traditional Chinese Medicine","startDate":"2025-08-31","conditions":"Ischemic Cerebral Infarction, Diabetes Mellitus","enrollment":3666},{"nctId":"NCT04824911","phase":"PHASE2","title":"Statin and Dual Antiplatelet Therapy to Prevent Early Neurological Deterioration in Branch Atheromatous Disease","status":"COMPLETED","sponsor":"Chang Gung Memorial Hospital","startDate":"2021-03-23","conditions":"Acute Stroke, Dual Antiplatelet Therapy, Statin","enrollment":376},{"nctId":"NCT05122780","phase":"PHASE4","title":"Prognostic Value of Precision Medicine in Patients With MINOCA (PROMISE Trial).","status":"ACTIVE_NOT_RECRUITING","sponsor":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","startDate":"2021-07-01","conditions":"Myocardial Infarction With Non-Obstructive Coronary Arteries","enrollment":120},{"nctId":"NCT04847752","phase":"","title":"Study of Predictive Factors Related to Prognosis of Patients With Ischemic Stroke Due to Large-artery Atherosclerosis","status":"RECRUITING","sponsor":"Tongji Hospital","startDate":"2021-03-01","conditions":"Ischemic Stroke, Large-Artery Atherosclerosis (Embolus/Thrombosis)","enrollment":1000},{"nctId":"NCT05504330","phase":"","title":"Cognitive Decline and Underlying Mechanisms in Asymptomatic Intracranial Artery Stenosis Patients","status":"RECRUITING","sponsor":"Anhui Medical University","startDate":"2022-08-15","conditions":"Asymptomatic Intracranial Stenosis, Cognitive Impairment, Cerebrovascular Event","enrollment":100},{"nctId":"NCT04925219","phase":"NA","title":"REmotely Supervised Exercise Therapy Trial 2","status":"UNKNOWN","sponsor":"Mid and South Essex NHS Foundation Trust","startDate":"2021-06-01","conditions":"Claudication, Intermittent, Peripheral Arterial Disease","enrollment":40},{"nctId":"NCT06112028","phase":"PHASE4","title":"Clinical Study of Tongxinluo Capsule in Preventing and Treating Restenosis After Intracranial and External Arterial Stenting","status":"NOT_YET_RECRUITING","sponsor":"Yanbin Li","startDate":"2023-10","conditions":"Stent Restenosis","enrollment":200},{"nctId":"NCT05996978","phase":"","title":"Intensive Drug Therapy for Ischemic Stroke Caused by Severe Intracranial Arterial Stenosis","status":"COMPLETED","sponsor":"Shanghai Yueyang Integrated Medicine Hospital","startDate":"2020-02-01","conditions":"Ischemic Stroke","enrollment":42},{"nctId":"NCT03635749","phase":"PHASE3","title":"Intensive Medical Therapy for High-risk Intracranial or Extracranial Atherosclerosis","status":"UNKNOWN","sponsor":"Beijing Tiantan Hospital","startDate":"2018-09-17","conditions":"Acute Stroke, Transient Ischemic Attack","enrollment":6100},{"nctId":"NCT03703635","phase":"NA","title":"Balloon Angioplasty for Symptomatic Intracranial Artery Stenosis","status":"UNKNOWN","sponsor":"Ministry of Science and Technology of the People´s Republic of China","startDate":"2018-10-17","conditions":"Intracranial Artery Stenosis","enrollment":512},{"nctId":"NCT05620615","phase":"","title":"Intensive Drug Therapy for Ischemic Stroke","status":"UNKNOWN","sponsor":"Shanghai Yueyang Integrated Medicine Hospital","startDate":"2018-07-01","conditions":"Ischemic Stroke","enrollment":42},{"nctId":"NCT05565976","phase":"PHASE2, PHASE3","title":"Dapagliflozin Effect in Cognitive Impairment in Stroke Trial","status":"UNKNOWN","sponsor":"Jaime Daniel Mondragon","startDate":"2020-08-01","conditions":"Stroke, Ischemic, Mild Cognitive Impairment, Dementia, Vascular","enrollment":270},{"nctId":"NCT00231803","phase":"NA","title":"The Canadian Prevention of Renal and Cardiovascular Endpoints Trial","status":"COMPLETED","sponsor":"Brendan Barrett","startDate":"2005-04","conditions":"Chronic Kidney Disease","enrollment":474},{"nctId":"NCT04581759","phase":"NA","title":"Endovascular Treatment and RIPC in Acute Ischemic Stroke","status":"UNKNOWN","sponsor":"First Affiliated Hospital Xi'an Jiaotong University","startDate":"2021-04-12","conditions":"Acute Ischemic Stroke, Endovascular Treatment","enrollment":300},{"nctId":"NCT04850001","phase":"","title":"Cognitive Decline in Asymptomatic Intracranial Stenosis Patients: A 1-Year Follow-Up Study","status":"UNKNOWN","sponsor":"Anhui Medical University","startDate":"2020-09-10","conditions":"Magnetic Resonance Imaging, Asymptomatic Intracranial Stenosis, Medical Treatment","enrollment":40},{"nctId":"NCT04744571","phase":"NA","title":"Safety and Efficacy of Drug-Coated Balloon Angioplasty for the Treatment of Chronic Total Occlusions","status":"UNKNOWN","sponsor":"Beijing Anzhen Hospital","startDate":"2021-02","conditions":"Coronary Artery Disease, Coronary Occlusion, Percutaneous Coronary Intervention","enrollment":200},{"nctId":"NCT04661709","phase":"PHASE4","title":"Efficacy and Safety of Wen Xin Granules for the Treatment of Unstable Angina Pectoris","status":"UNKNOWN","sponsor":"Guang'anmen Hospital of China Academy of Chinese Medical Sciences","startDate":"2021-03-01","conditions":"Coronary Heart Disease, Unstable Angina, Chinese Herbal Medicine","enrollment":502},{"nctId":"NCT03372785","phase":"","title":"The Success of Opening Concurrent CTO leSion to Improve Cardiac Function Trial in Patients With Multi-vessel Disease","status":"UNKNOWN","sponsor":"Beijing Anzhen Hospital","startDate":"2018-04-10","conditions":"Chronic Total Occlusion of Coronary Artery, Percutaneous Coronary Intervention, Coronary Artery Disease","enrollment":240},{"nctId":"NCT04434365","phase":"PHASE1, PHASE2","title":"Effect of Berberine for Endothelial Function and Intestinal Microflora in Patients With Coronary Artery Disease","status":"UNKNOWN","sponsor":"Peking Union Medical College Hospital","startDate":"2019-06-21","conditions":"Stable Coronary Artery Disease, Percutaneous Coronary Intervention","enrollment":24},{"nctId":"NCT00687076","phase":"PHASE4","title":"Effectiveness of Intensive Lipid Modification Medication in Preventing the Progression of Peripheral Arterial Disease (The ELIMIT Study)","status":"COMPLETED","sponsor":"Baylor College of Medicine","startDate":"2004-04","conditions":"Peripheral Arterial Disease","enrollment":102},{"nctId":"NCT04091412","phase":"PHASE4","title":"Study of Collateral Circulation in Patients With Symptomatic Intracranial Anterior Circulation Occlusion","status":"UNKNOWN","sponsor":"The Second Hospital of Hebei Medical University","startDate":"2019-05-05","conditions":"Collateral Circulation, Large-artery Occlusion, Cerebral Infarction","enrollment":500},{"nctId":"NCT02767401","phase":"PHASE4","title":"The Success of Opening Single CTO Lesions to Improve Myocardial Viability Study (SOS-comedy)","status":"COMPLETED","sponsor":"The First Affiliated Hospital of Dalian Medical University","startDate":"2015-09-15","conditions":"Hibernation, Myocardial, Complete Occlusion of Coronary Artery","enrollment":200},{"nctId":"NCT03431909","phase":"PHASE4","title":"Evaluation Of HUK in Acute Stroke Patients: MRS and CTP","status":"COMPLETED","sponsor":"Xuanwu Hospital, Beijing","startDate":"2014-01-01","conditions":"Acute Ischemic Stroke","enrollment":80},{"nctId":"NCT02539810","phase":"PHASE4","title":"Renal Artery Stenting in Patients With Documented Resistant Hypertension and Atherosclerotic Renal Artery Stenosis (ANDORRA)","status":"TERMINATED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2015-09","conditions":"Hypertension, Hypertension Resistant to Conventional Therapy, Angiographically Proven Grade III Unilateral or Bilateral Atherosclerotic Renal Artery Stenosis (ARAS) Greater Than or Equal to 60 Percent","enrollment":4},{"nctId":"NCT02800174","phase":"NA","title":"Smart Nitinol Stent System for the Treatment of Severe Atherosclerotic Carotid Stenosis","status":"COMPLETED","sponsor":"Beijing Jishuitan Hospital","startDate":"2006-06","conditions":"Carotid Artery Stenosis","enrollment":103},{"nctId":"NCT00979940","phase":"NA","title":"Effects of Short Term, High Dose Atorvastatin Therapy on Periprocedural Myonecrosis and Platelet Inhibition After Percutaneous Coronary Intervention (PCI)","status":"TERMINATED","sponsor":"Indiana University School of Medicine","startDate":"2008-11","conditions":"Coronary Artery Disease","enrollment":60},{"nctId":"NCT02411903","phase":"PHASE4","title":"The Dynamic Effect of Non-cytochrome P450 Isoenzyme 3A4（CYP3A4）-Metabolized and Cytochrome P450 Isoenzyme 3A4（CYP3A4）-Metabolized Statins on Clopidogrel Resistance in Patients With Cerebral Infarction","status":"UNKNOWN","sponsor":"The Third Affiliated Hospital of Guangzhou Medical University","startDate":"2015-03","conditions":"Cerebral Infarction, Clopidogrel,Poor Metabolism of (Disorder)","enrollment":160},{"nctId":"NCT02357212","phase":"NA","title":"Early Invasive Versus Conservative Therapy in Women With an Acute Coronary Syndrome","status":"COMPLETED","sponsor":"University of Florida","startDate":"2009-04","conditions":"Acute Coronary Syndrome","enrollment":40},{"nctId":"NCT01394848","phase":"PHASE4","title":"Safety and Efficacy Study of Endothelial Progenitor Cell Capture Stent With 1 Months Dual Antiplatelet Therapy","status":"TERMINATED","sponsor":"Yonsei University","startDate":"2011-10","conditions":"Stable Angina","enrollment":1},{"nctId":"NCT01558245","phase":"PHASE2","title":"Tissue Kallikrein Preventing the Restenosis After Stenting of Symptomatic MCA Atherosclerotic Stenosis","status":"UNKNOWN","sponsor":"Jinling Hospital, China","startDate":"2011-12","conditions":"Cerebrovascular Disease","enrollment":99},{"nctId":"NCT01700075","phase":"PHASE4","title":"Physical and Chemical Study of Atherosclerosis Mechanisms","status":"COMPLETED","sponsor":"Nazarbayev University","startDate":"2009-01","conditions":"Myocardial Infarction, Coronary Artery Diseases, Diabetes Mellitus, Type 2","enrollment":97},{"nctId":"NCT01665235","phase":"NA","title":"Blood Pressure Variability and the Prognosis of Ischemic Stroke With Intracranial Artery Stenosis","status":"UNKNOWN","sponsor":"RenJi Hospital","startDate":"2012-08","conditions":"Blood Pressure Variability, Intracranial Artery Stenosis","enrollment":200},{"nctId":"NCT01572623","phase":"PHASE4","title":"Clopidogrel and Atorvastatin Treatment During Carotid Artery Stenting","status":"UNKNOWN","sponsor":"Campus Bio-Medico University","startDate":"2011-07","conditions":"Carotid Stenosis","enrollment":150},{"nctId":"NCT01455935","phase":"PHASE2","title":"Wake up Symptomatic Stroke - Benefit of Intravenous Clot Busters or Endovascular Intervention","status":"UNKNOWN","sponsor":"Jacobs Neurological Institute","startDate":"2011-11","conditions":"Stroke","enrollment":90},{"nctId":"NCT00930670","phase":"PHASE4","title":"Evaluation of the Influence of Statins and Proton Pump Inhibitors on Clopidogrel Antiplatelet Effects","status":"COMPLETED","sponsor":"Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec","startDate":"2009-06","conditions":"Coronary Artery Disease","enrollment":320},{"nctId":"NCT01335048","phase":"PHASE4","title":"Atorvastatin and Clopidogrel HIgh DOse in Stable Patients With Residual High Platelet Activity","status":"COMPLETED","sponsor":"Ospedale Misericordia e Dolce","startDate":"2011-04","conditions":"Stable Angina","enrollment":50},{"nctId":"NCT01502943","phase":"PHASE4","title":"Studies of Traditional Chinese Medicine Clinical Efficacy Evaluation Index","status":"COMPLETED","sponsor":"Liaoning University of Traditional Chinese Medicine","startDate":"2011-05","conditions":"Coronary Heart Disease, Stable Angina Pectoris","enrollment":480},{"nctId":"NCT00691314","phase":"NA","title":"Efficacy and Safety of Stent Implantation in Symptomatic Extra- and Intracranial Artery Stenosis","status":"COMPLETED","sponsor":"Peking Union Medical College Hospital","startDate":"2008-06","conditions":"Stroke, Transient Ischemic Attack, Atherosclerosis","enrollment":300},{"nctId":"NCT00235950","phase":"PHASE4","title":"Assessment of the Lipid Lowering Effect of Rosuvastatin Compared to Atorvastatin in Subjects With Coronary Heart Disease","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2004-01","conditions":"Coronary Heart Disease","enrollment":255},{"nctId":"NCT00734123","phase":"PHASE4","title":"Early Detection of Atherosclerosis: a Randomized Trial in the Primary Prevention of Cardiovascular Diseases.","status":"UNKNOWN","sponsor":"Hospital Arnau de Vilanova","startDate":"2008-04","conditions":"Atherosclerosis, Cardiovascular Diseases","enrollment":2948}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"atorvastatin and clopidogrel","genericName":"atorvastatin and clopidogrel","companyName":"Ospedale Misericordia e Dolce","companyId":"ospedale-misericordia-e-dolce","modality":"Small molecule","firstApprovalDate":"","aiSummary":"This combination reduces cholesterol levels and prevents blood clots by inhibiting HMG-CoA reductase and platelet aggregation, respectively. Used for Secondary prevention of cardiovascular events in patients with acute coronary syndrome, Prevention of stent thrombosis following percutaneous coronary intervention, Reduction of cardiovascular risk in patients with established coronary artery disease.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}